Viewing Study NCT07073950

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2026-06-01 @ 11:01 PM
Study NCT ID: NCT07073950
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Obstructive Pulmonary Disease View
None Hyperinflation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metered Dose Inhalers (MDI) View
None Inhaled Corticosteroid (ICS) View
None Long-acting muscarinic antagonist (LAMA) View
None Long-acting beta2 agonist (LABA) View